KCM
MEDP icon

Kendall Capital Management’s Medpace MEDP Stock Holding History

Kendall Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Sell
2,300
-155
-6% -$79.4K 0.23% 112
2025
Q4 		$1.38M Sell
2,455
-245
-9% -$139K 0.29% 89
2025
Q3 		$1.39M Sell
2,700
-155
-5% -$67.7K 0.31% 75
2025
Q2 		$896K Sell
2,855
-60
-2% -$18K 0.24% 106
2025
Q1 		$888K Sell
2,915
-50
-2% -$16.8K 0.26% 104
2024
Q4 		$985K Sell
2,965
-155
-5% -$52.6K 0.29% 89
2024
Q3 		$1.04M Sell
3,120
-95
-3% -$36.1K 0.32% 84
2024
Q2 		$1.32M Sell
3,215
-225
-7% -$89.1K 0.44% 66
2024
Q1 		$1.39M Sell
3,440
-111
-3% -$39K 0.48% 65
2023
Q4 		$1.09M Sell
3,551
-199
-5% -$53.7K 0.42% 76
2023
Q3 		$908K Sell
3,750
-670
-15% -$171K 0.4% 77
2023
Q2 		$1.06M Hold
4,420
– – 0.47% 75
2023
Q1 		$831K Hold
4,420
– – 0.4% 83
2022
Q4 		$939K Sell
4,420
-25
-0.6% -$5K 0.47% 69
2022
Q3 		$699K Hold
4,445
– – 0.41% 78
2022
Q2 		$665K Hold
4,445
– – 0.37% 87
2022
Q1 		$727K Hold
4,445
– – 0.35% 90
2021
Q4 		$967K Sell
4,445
-355
-7% -$74.3K 0.46% 74
2021
Q3 		$909K Sell
4,800
-200
-4% -$36.5K 0.49% 67
2021
Q2 		$883K Sell
5,000
-250
-5% -$43.1K 0.5% 64
2021
Q1 		$861K Buy
5,250
+190
+4% +$29.1K 0.53% 62
2020
Q4 		$704K Sell
5,060
-5
-0.1% -$630 0.51% 64
2020
Q3 		$566K Buy
5,065
+620
+14% +$71.7K 0.49% 65
2020
Q2 		$413K Buy
4,445
+1,410
+46% +$120K 0.4% 73
2020
Q1 		$223K Buy
+3,035
New +$263K 0.25% 93

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Kendall Capital Management's MEDP Position: Q1 2026 in Review

Kendall Capital Management reduced its Medpace (MEDP) stake by 6.3% in Q1 2026, selling an estimated $79.4K and leaving 2,300 shares worth $1.1M. The position accounts for 0.23% of the portfolio, ranked #112.

Kendall Capital Management first reported a position in MEDP in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.39M in Q1 2024. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Kendall Capital Management held 2,300 shares of Medpace worth $1.1M as of Q1 2026.
  • Kendall Capital Management sold 155 Medpace shares in Q1 2026, an estimated $79.4K.
  • Medpace made up 0.23% of Kendall Capital Management's portfolio in Q1 2026, its #112 holding.
  • Kendall Capital Management first reported a position in Medpace in Q1 2020 and has held it in 25 quarters since.
  • Kendall Capital Management's Medpace position peaked at $1.39M in Q1 2024.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.